申请人:——
公开号:US20020052384A1
公开(公告)日:2002-05-02
This invention discloses pyrimidine derivatives, and pharmaceutically acceptable salts and prodrugs thereof, useful in therapeutically and/or prophylactically treating patients with an illness. Such illnesses include cancer, and secondary infections caused by
Pneumocystis carinii
and
Toxoplasmosis gondii
in immunocompromised patients. The compounds themselves, methods of making these compounds, and methods of using these compounds are all disclosed.
本发明披露了嘧啶衍生物及其药学上可接受的盐和前药,用于治疗患有疾病的患者的治疗和/或预防。这种疾病包括癌症和免疫功能受损的患者因肺孢子菌和弓形虫感染而引起的继发感染。本发明披露了这些化合物本身,制备这些化合物的方法以及使用这些化合物的方法。